Medikaloka Hermina PT
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more
Medikaloka Hermina PT (HEAL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.032x
Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has a cash flow conversion efficiency ratio of 0.032x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp225.37 Billion) by net assets (Rp7.01 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medikaloka Hermina PT - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Medikaloka Hermina PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medikaloka Hermina PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medikaloka Hermina PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jointo Energy Investment Co Ltd Hebei
SHE:000600
|
0.096x |
|
Celltrion Pharm Inc
KQ:068760
|
0.055x |
|
Mach Natural Resources LP
NYSE:MNR
|
0.054x |
|
Sunshine Insurance Group Company Limited
F:E57
|
N/A |
|
SENSIRION HOLDING
F:1Q3
|
N/A |
|
Daktronics Inc
NASDAQ:DAKT
|
0.040x |
|
LG Household & Healthcare Ltd Pref
KO:051905
|
0.029x |
|
Transportadora de Gas del Norte SA Class C
BA:TGNO4
|
0.129x |
Annual Cash Flow Conversion Efficiency for Medikaloka Hermina PT (2015–2024)
The table below shows the annual cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp5.87 Trillion | Rp1.14 Trillion | 0.194x | -23.61% |
| 2023-12-31 | Rp5.20 Trillion | Rp1.32 Trillion | 0.254x | +136.20% |
| 2022-12-31 | Rp4.69 Trillion | Rp503.58 Billion | 0.107x | -74.60% |
| 2021-12-31 | Rp4.39 Trillion | Rp1.86 Trillion | 0.423x | +27.07% |
| 2020-12-31 | Rp3.38 Trillion | Rp1.13 Trillion | 0.333x | +60.80% |
| 2019-12-31 | Rp2.76 Trillion | Rp572.58 Billion | 0.207x | +103.10% |
| 2018-12-31 | Rp2.37 Trillion | Rp241.67 Billion | 0.102x | -79.03% |
| 2017-12-31 | Rp956.53 Billion | Rp465.08 Billion | 0.486x | +68.84% |
| 2016-12-31 | Rp1.26 Trillion | Rp362.85 Billion | 0.288x | +7.84% |
| 2015-12-31 | Rp957.59 Billion | Rp255.71 Billion | 0.267x | -- |